In continuation to the scientific discussions on COVID-19 vaccines research, WHO R&D Blueprint is organizing a consultation to identify vaccine research priorities to facilitate further contributions of vaccines to achieve improved control of the pandemic everywhere. This will take place on Friday, 28 January 2022 from 13h00 to 19h00 (CET) Geneva time.

During this forthcoming consultation global experts will review the available evidence, enumerate knowledge gaps, and outline research priorities related to a pan-sarbecovirus vaccine. The objectives of the meeting are to:

– Review scientific advances and development approaches to enable the development of a pan-sarbecovirus vaccine.
– Provide an overview of various candidate vaccines under development.
– Outline novel approaches for evaluation of pan-sarbecovirus vaccines, including in the context of the different variants of concern.